ChitogenX Inc. (CSE:CHGX)
Canada · Delayed Price · Currency is CAD | Market Cap | 415.65K -83.3% |
| Revenue (ttm) | n/a |
| Net Income | -1.55M |
| EPS | -0.02 |
| Shares Out | 83.13M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 120,000 |
| Open | 0.0050 |
| Previous Close | 0.0050 |
| Day's Range | 0.0050 - 0.0050 |
| 52-Week Range | 0.0050 - 0.0450 |
| Beta | -2.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 28, 2026 |
About ChitogenX
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirk... [Read more]
Financial Performance
Financial StatementsNews
CHITOGENX LAUNCHES BURN AND SKIN REPAIR DEVELOPMENT PROGRAM
Significant unmet medical needs in US $19B burn and skin defects market New patent in US and Canada supports ChitogenX' proprietary chitosan-based biopolymer as ideal combination with cellular regener...